HC Wainwright Has Weak Forecast for OPKO Health Q4 Earnings
OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Stock analysts at HC Wainwright dropped their Q4 2026 earnings per share (EPS) estimates for OPKO Health in a note issued to investors on Monday, March...
MarketBeat·2d ago
More News
OPKO Health (NASDAQ:OPK) Given New $1.50 Price Target at Barrington Research
Barrington Research dropped their price objective on shares of OPKO Health from $2.25 to $1.50 and set an "outperform" rating for the company in a research note on Monday...
OPKO Health beats Q4 earnings and revenue estimates, but sales decline and gross margin narrows.
Zacks·8d ago
OPKO Health Q4 Earnings Call Highlights
OPKO Health (NASDAQ:OPK) executives said the company exited 2025 with tremendous momentum, citing efforts to reposition its diagnostics business for a return to profitability, advance its ModeX...
MarketBeat·8d ago
OPKO Health (NASDAQ:OPK) Announces Earnings Results
OPKO Health (NASDAQ:OPK - Get Free Report) released its quarterly earnings results on Thursday. The biotechnology company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts...
MarketBeat·8d ago
OPKO Health (OPK) Q4 2025 Earnings Call Transcript
Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for OPKO Health (OPK) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·8d ago
OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates
OPKO Health (OPK) delivered earnings and revenue surprises of +39.39% and +7.56%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·8d ago
OPKO Health (OPK) Projected to Post Quarterly Earnings on Thursday
OPKO Health (NASDAQ:OPK) will be releasing its Q4 2025 earnings after the market closes on Thursday, February 26. (View Earnings Report at...
MarketBeat·16d ago
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?
OPKO Health targets 30% growth in fiscal 2026, driven by RAYALDEE sales, strategic deals and pipeline progress, despite competitive pressures and reliance risks